Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Sponsor: Janssen Research & Development, LLC
Summary
The purpose of this study is to collect long-term follow-up data on delayed adverse events after administration of ciltacabtagene autoleucel (cilta-cel), and to characterize and understand the long-term safety profile of cilta-cel.
Official title: Long-term Follow-up Study for Participants Previously Treated With Ciltacabtagene Autoleucel
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
295
Start Date
2022-03-09
Completion Date
2037-10-30
Last Updated
2026-03-23
Healthy Volunteers
No
Conditions
Interventions
Cilta-cel
Participants who had received cilta-cel in previous studies will be followed up in this study. No additional study treatment will be administered to participants in this study.
Locations (50)
Mayo Clinic Cancer Center-Scottsdale
Phoenix, Arizona, United States
City of Hope
Duarte, California, United States
University of California San Francisco
San Francisco, California, United States
Stanford University Medical Center
Stanford, California, United States
Moffitt Cancer Center
Tampa, Florida, United States
Emory University
Atlanta, Georgia, United States
Northwestern University
Chicago, Illinois, United States
University of Chicago
Chicago, Illinois, United States
Indiana University
Indianapolis, Indiana, United States
Kansas University Medical Center
Westwood, Kansas, United States
Dana Farber Cancer Institute
Boston, Massachusetts, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Massachusetts General Hospital
Boston, Massachusetts, United States
Barbara Ann Karmanos Cancer Institute
Detroit, Michigan, United States
Mayo Clinic Rochester
Rochester, Minnesota, United States
Washington University School Of Medicine
St Louis, Missouri, United States
Hackensack University Medical Center
Hackensack, New Jersey, United States
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Roswell Park Cancer Institute
Buffalo, New York, United States
Mount Sinai Medical Center
New York, New York, United States
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Montefiore Medical Center
The Bronx, New York, United States
Levine Cancer Institute
Charlotte, North Carolina, United States
University of Pennsylvania
Philadelphia, Pennsylvania, United States
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States
Sarah Cannon Research Institute
Nashville, Tennessee, United States
MD Anderson Cancer Center
Houston, Texas, United States
Froedtert Memorial
Milwaukee, Wisconsin, United States
UZ Gent
Ghent, Belgium
UZ Leuven
Leuven, Belgium
Peking University Third Hospital
Beijing, China
West China Hospital Si Chuan University
Chengdu, China
Fujian Medical University Union Hospital
Fuzhou, China
Sun Yat-sen University Cancer Hospital
Guangzhou, China
First Hospital, Zhejiang University Medical College
Hangzhou, China
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School
Nanjing, China
Jiangsu Province Hospital
Nanjing, China
Shanghai Changzheng Hospital
Shanghai, China
Ruijin Hospital Shanghai Jiao Tong University
Shanghai, China
Shanghai Fourth People s Hospital
Shanghai, China
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, China
CHRU de Lille Hopital Claude Huriez
Nord, France
Hopital Saint Louis
Paris, France
Tel Aviv Sourasky Medical Center
Tel Aviv, Israel
Nagoya City University Hospital
Nagoya, Japan
Japanese Red Cross Medical Center
Shibuya City, Japan
VU Medisch Centrum
Amsterdam, Netherlands
University Medical Center Groningen
Groningen, Netherlands
Clinica Univ. de Navarra
Pamplona, Spain
Hosp Clinico Univ de Salamanca
Salamanca, Spain